ARKG vs. ARKF

Last updated Jun 24, 2026

ARKG (ARK Genomic Revolution Multi-Sector ETF) and ARKF (ARK Fintech Innovation ETF) are both exchange-traded funds - ARKG is a Health & Biotech Equities fund actively managed by ARK, while ARKF is a Blockchain fund actively managed by ARK. Both are actively managed. Over the past 5 years, ARKG returned -16.56%/yr vs -6.28%/yr for ARKF. A 0.75 correlation means they provide meaningful diversification when combined. Both charge a 0.75% expense ratio.

Performance

ARKG vs. ARKF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK Fintech Innovation ETF (ARKF). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ARKG achieves a 24.30% return, which is significantly higher than ARKF's -18.35% return.

ARKG

• 1D: -1.07%
• 1M: 17.41%
• YTD: 24.30%
• 6M: 19.48%
• 1Y: 52.71%
• 3Y*: 3.17%
• 5Y*: -16.56%
• 10Y*: 8.67%

ARKF

• 1D: -1.37%
• 1M: -4.80%
• YTD: -18.35%
• 6M: -20.79%
• 1Y: -19.31%
• 3Y*: 24.85%
• 5Y*: -6.28%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ARKG vs. ARKF - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
ARKG ARK Genomic Revolution Multi-Sector ETF	24.30%	23.04%	-28.24%	16.22%	-53.90%	-33.92%	180.40%	22.20%
ARKF ARK Fintech Innovation ETF	-18.35%	28.67%	34.34%	93.27%	-65.07%	-17.82%	108.03%	20.45%

Correlation

The correlation between ARKG and ARKF is 0.62, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.62
Correlation (3Y) Calculated over the trailing 3-year period	0.68
Correlation (5Y) Calculated over the trailing 5-year period	0.76
Correlation (All Time) Calculated using the full available price history since Feb 4, 2019	0.75

The correlation between ARKG and ARKF shifts across timeframes, from 0.62 (1 year) to 0.76 (5 years), reflecting how their relationship changes across market environments.

ARKG vs. ARKF - Sectors Allocation Comparison

Sectors	ARKG	ARKF
Healthcare	99.3%	0.2%
Financial Services	0.5%	25.5%
Basic Materials	-	-
Communication Services	-	9.6%
Consumer Cyclical	-	13.7%
Consumer Defensive	-	-
Energy	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	39.4%
Utilities	-	-

Return for Risk

ARKG vs. ARKF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKG

ARKG Risk / Return Rank: 36
ARKG Sharpe Ratio Rank: 36
ARKG Sortino Ratio Rank: 38
ARKG Omega Ratio Rank: 34
ARKG Calmar Ratio Rank: 40
ARKG Martin Ratio Rank: 32

ARKF

ARKF Risk / Return Rank: 5
ARKF Sharpe Ratio Rank: 4
ARKF Sortino Ratio Rank: 4
ARKF Omega Ratio Rank: 4
ARKF Calmar Ratio Rank: 5
ARKF Martin Ratio Rank: 5

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARKG vs. ARKF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Genomic Revolution Multi-Sector ETF (ARKG) and ARK Fintech Innovation ETF (ARKF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ARKG	ARKF	Difference
Sharpe ratio: Return per unit of total volatility	1.25	-0.58	+1.83
Sortino ratio: Return per unit of downside risk	1.91	-0.63	+2.55
Omega ratio: Gain probability vs. loss probability	1.22	0.93	+0.29
Calmar ratio: Return relative to maximum drawdown	1.93	-0.50	+2.43
Martin ratio: Return relative to average drawdown	4.58	-0.90	+5.48

ARKG vs. ARKF - Sharpe Ratio Comparison

The current ARKG Sharpe Ratio is 1.25, which is higher than the ARKF Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of ARKG and ARKF, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ARKG vs. ARKF - Drawdown Comparison

The maximum ARKG drawdown since its inception was -83.59%, which is greater than ARKF's maximum drawdown of -78.63%. Use the drawdown chart below to compare losses from any high point for ARKG and ARKF.

Drawdown Indicators

	ARKG	ARKF	Difference
Max Drawdown Largest peak-to-trough decline	-83.59%	-78.63%	-4.96%
Max Drawdown (1Y) Largest decline over 1 year	-27.51%	-38.50%	+10.99%
Max Drawdown (3Y) Largest decline over 3 years	-51.96%	-38.50%	-13.46%
Max Drawdown (5Y) Largest decline over 5 years	-80.18%	-75.30%	-4.88%
Max Drawdown (10Y) Largest decline over 10 years	-83.59%	—	—
Current Drawdown Current decline from peak	-67.78%	-38.80%	-28.98%
Average Drawdown Average peak-to-trough decline	-36.02%	-34.96%	-1.06%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.53%	21.58%	-10.05%

Volatility

ARKG vs. ARKF - Volatility Comparison

ARK Genomic Revolution Multi-Sector ETF (ARKG) has a higher volatility of 15.19% compared to ARK Fintech Innovation ETF (ARKF) at 10.86%. This indicates that ARKG's price experiences larger fluctuations and is considered to be riskier than ARKF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARKG	ARKF	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.19%	10.86%	+4.33%
Volatility (6M) Calculated over the trailing 6-month period	30.91%	25.24%	+5.67%
Volatility (1Y) Calculated over the trailing 1-year period	42.54%	33.47%	+9.07%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	45.93%	42.93%	+3.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	41.29%	39.75%	+1.54%

ARKG vs. ARKF - Expense Ratio Comparison

Both ARKG and ARKF have an expense ratio of 0.75%.

Dividends

ARKG vs. ARKF - Dividend Comparison

ARKG has not paid dividends to shareholders, while ARKF's dividend yield for the trailing twelve months is around 0.11%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
ARKF ARK Fintech Innovation ETF	0.11%	0.09%	0.00%	0.00%	0.00%	0.00%	0.37%	1.25%	0.00%	0.00%
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%

Frequently Asked Questions

Can I hold both ARKG and ARKF in my portfolio?

ARKG and ARKF have a correlation of 0.62, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ARKG or ARKF?

ARKG has higher volatility (15.19%) compared to ARKF (10.86%). In terms of maximum drawdown, ARKG dropped -83.59% vs ARKF's -78.63%.

Which ETF is better, ARKG or ARKF?

On 5-year performance, ARKF leads with -6.28% vs -16.56% for ARKG. Both ETFs have the same 0.75% expense ratio. On volatility, ARKF has been the lower-risk option at 10.86%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, ARKG or ARKF?

Over the 5-year period, ARKF has performed better with a -6.28% return vs -16.56%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, ARKG or ARKF?

ARKG and ARKF have the same expense ratio: 0.75% per year.

Which ETF pays a higher dividend yield, ARKG or ARKF?

ARKF has the higher dividend yield at 0.11%, compared with 0.00% for ARKG.

What is the main difference between ARKG and ARKF?

ARKG is categorized as Health & Biotech Equities, while ARKF is Blockchain.

Which has better risk-adjusted returns?

ARKG currently has the higher Sharpe Ratio (1.25 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.